BACKGROUND Initiating therapy with a low CD4 cell count is associated with a substantially greater risk of disease progression and death than earlier initiation. We examined factors associated with late presentation of HIV using the new European consensus definition (CD4 cell count <350 cells/mm3) and mortality. METHODS Patients newly diagnosed with HIV infection at a UK clinic were recruited from January 1996 to May 2010. Factors associated with late presentation were assessed using logistic regression. Factors associated with mortality rates were analysed using Poisson regression. RESULTS Of the 1536 included in the analysis, 86% were male and 10% were aged 50 years and older. Half the cohort (49%) had a CD4 cell count belo...
It is recognised that those diagnosed with HIV infection over the age of 50 have higher rates of mor...
Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
Introduction: With the advent of combined antiretroviral therapy (cART), more people infected with H...
BACKGROUND: Initiating therapy with a low CD4 cell count is associated with a substantially greater ...
INTRODUCTION: With the advent of combined antiretroviral therapy (cART), more people infected with H...
BACKGROUND: We aimed at evaluating frequency and factors associated with late presentation and adva...
Background: We aimed at evaluating frequency and factors associated with late presentation and advan...
We assessed CD4 count at initial presentation for HIV care among [greater than or equal to]50-year-o...
We assessed CD4 count at initial presentation for HIV care among ≥50-year-olds from 1997-2007 in 13 ...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
BACKGROUND: the number and proportion of adults diagnosed with HIV infection aged 50 years and older...
Abstract Background We aimed at evaluating frequency and factors associated with late presentation a...
© 2018 World Health Organization. Background. Severely immunocompromised human immunodefciency virus...
Objectives. We investigated immune phenotypes of HIV+ patients who present late, considering late pr...
Background To study whether the association between the CD4/CD8 ratio variation over time and the de...
It is recognised that those diagnosed with HIV infection over the age of 50 have higher rates of mor...
Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
Introduction: With the advent of combined antiretroviral therapy (cART), more people infected with H...
BACKGROUND: Initiating therapy with a low CD4 cell count is associated with a substantially greater ...
INTRODUCTION: With the advent of combined antiretroviral therapy (cART), more people infected with H...
BACKGROUND: We aimed at evaluating frequency and factors associated with late presentation and adva...
Background: We aimed at evaluating frequency and factors associated with late presentation and advan...
We assessed CD4 count at initial presentation for HIV care among [greater than or equal to]50-year-o...
We assessed CD4 count at initial presentation for HIV care among ≥50-year-olds from 1997-2007 in 13 ...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
BACKGROUND: the number and proportion of adults diagnosed with HIV infection aged 50 years and older...
Abstract Background We aimed at evaluating frequency and factors associated with late presentation a...
© 2018 World Health Organization. Background. Severely immunocompromised human immunodefciency virus...
Objectives. We investigated immune phenotypes of HIV+ patients who present late, considering late pr...
Background To study whether the association between the CD4/CD8 ratio variation over time and the de...
It is recognised that those diagnosed with HIV infection over the age of 50 have higher rates of mor...
Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
Introduction: With the advent of combined antiretroviral therapy (cART), more people infected with H...